SecBot SecBot
COURT-RULING ·Filed Apr 20, 2026

HKMPF

HIKMA PHARMACEUTICALS USA
NEUTRAL
Impact 1/10
Horizonmonths Processed3mo ago CourtCourt Ruling · courtlistener.com
Court ruling (district)
Actionable Insight • Neutral

This procedural ruling has no trading implications. Monitor for substantive rulings on the underlying dispute (e.g., motions to dismiss, summary judgment, or trial dates) which could affect Hikma's competitive position or IP exposure.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
HKMPF ▲ +13.59% at T+60d
NEUTRAL call +13.59% · α vs SPY +7.75% · entry $18.72 → $21.26
Entry = T+0 close
Apr 21, 2026
via day close
T+1d
-3.29%
call -3.29% · α -4.30%
$18.10
settled 6mo ago
T+5d
-3.29%
call -3.29% · α -4.37%
$18.10
settled 6mo ago
T+20d
+2.05%
call +2.05% · α -2.16%
$19.10
settled 5mo ago
T+60d
+13.59%
call +13.59% · α +7.75%
$21.26
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

The court granted a motion to seal confidential information from a December 2025 teleconference transcript in the ongoing Hikma Pharmaceuticals USA v. InfoRLife SA litigation. The ruling is a routine procedural order that seals defendants' sensitive R&D information — it does not address the merits of the underlying case, award damages, or issue any injunction against Hikma. The filing has no material financial or operational impact on Hikma Pharmaceuticals.

Court Ruling Details

Ruling Date
Apr 29, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
T. Quinn (U.S.M.J.)
Case Type
other
Ruling Type
procedural
Outcome
PARTIAL — mixed ruling, some claims won/lost
Precedent Risk
LOW

Key Facts

  • Hikma Pharmaceuticals USA is the plaintiff in a lawsuit against InfoRLife SA and WG Critical Care LLC
  • The court granted defendants' motion to seal confidential information from a December 15, 2025 teleconference transcript
  • The sealed material relates to defendants' sensitive research and development efforts
  • The order is procedural — no damages, injunction, or merits ruling was issued
  • The motion was unopposed by Hikma

Financial Impact

No financial impact — this is a routine sealing order with no monetary award or business restriction

Risk Factors

  • The underlying lawsuit remains active — future adverse rulings could create IP or competitive risk
  • Sealed materials may contain information relevant to Hikma's product pipeline or market position, but the content is not publicly available

Market Snapshot

Analyst Consensus
86% bullish (21 analysts)

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-id87lg7d-HKMPF
3 reports for HKMPF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HKMPF — sortable, filterable
TypeNow
Jun 4, 2026
20w ago
Court Ruling
BULLISH ★ 7/10
$19.29 $22.19▲ +15.02%▲ +13.14%$22.14 (+14.75%)
Apr 20, 2026
27w ago
Court Ruling
NEUTRAL ★ 1/10
$18.72 $21.26▲ +13.59%▲ +7.75%$22.14 (+18.27%)
Apr 20, 2026
27w ago
Court Ruling
NEUTRAL ★ 1/10
$18.72 $21.26▲ +13.59%▲ +7.75%$22.14 (+18.27%)
Showing 3 of 3

US Market Status

Market Closed — Opens in 8h 19m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jul 3, 2026